Labshake search
Citations for Trevigen :
1 - 17 of 17 citations for BSJ 02 162 since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... mouse laminin1 (Trevigen, USA. Cat#: 3401-010-02), tricaine-S (MS-222 ...
-
bioRxiv - Cancer Biology 2020Quote: ... Cells were combined with molten LMAgarose (Trevigen, 4250-050-02) and placed into comet suitable slides ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 20 µL/mL XTT activator (Trevigen, 4891-025-02) dissolved in PBS (pH 7.4 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 20 μL/mL XTT activator (Trevigen, 4891-025-02) dissolved in PBS (pH 7.4 ...
-
bioRxiv - Molecular Biology 2023Quote: ... ICOs were cultured in Basement Membrane Extract (BME, Trevigen, 3533-010-02) and the expansion medium was refreshed every 3 days ...
-
bioRxiv - Cancer Biology 2022Quote: ... MM231 cells were added to Cultrex Basement Membrane Extract (BME) (Trevigen; 3533-005-02) at a density of 500 cells/100 µL BME ...
-
bioRxiv - Cancer Biology 2022Quote: ... Transformed cells with 50% basement membrane matrix (BME) type 3 (3632-005-02, Trevigen) (total 100 µL volume ...
-
bioRxiv - Cancer Biology 2023Quote: ... The cell pellets were seeded in growth factor-reduced BME (Trevigen, 3533-010-02) and cultured in kidney organoid medium (AdvDF+++ supplemented with 1.5% B27 supplement (Gibco) ...
-
bioRxiv - Cancer Biology 2024Quote: ... incorporating 5% Cultrex® Reduced Growth Factor Basement Membrane Matrix (BME, Trevigen, 3533-001-02). Organoids underwent treatment with either vehicle or specified ...
-
bioRxiv - Cancer Biology 2022Quote: ... organoids were resuspended in a mixture of 80% Cultrex Basement Membrane Extracts (BME) (Amsbio/Trevigen, # 3533-010-02) and 20% mammary tumor organoid medium (MTM) ...
-
bioRxiv - Cancer Biology 2024Quote: ... PDO fragments were embedded in Cultrex growth factor-reduced basement membrane extract type II (Trevigen, 3533-001-02), 50 µL drops were plated into a 24-well plate ...
-
bioRxiv - Cell Biology 2024Quote: ... which were subsequently embedded in 30 µl droplets of basement membrane extract (BME; Cat#3532-010-02, Trevigen). Next ...
-
bioRxiv - Cancer Biology 2024Quote: ... Cells were diluted in 50 μl media (RPMI +10% FBS) and 50μl Cultrex PathClear BME (Trevigen # 3632-005-02). Cells were injected subcutaneously into the shoulders and flanks of six eight-week-old Prkdcem26Cd52Il2rgem26Cd22/NjuCrl (NCG ...
-
bioRxiv - Cancer Biology 2023Quote: ... The pellet was resuspended in 10 mg/mL cold Cultrex growth factor reduced BME type 2 (Trevigen, 3533-010-02) and 40 μL drops of BME-cell suspension were allowed to solidify on pre-warmed 24-well suspension culture plates (Greiner ...
-
bioRxiv - Cancer Biology 2024Quote: ... Cells were diluted in 50 μl media (RPMI +10% FBS) and 50 μl Cultrex PathClear BME (Trevigen # 3632-005-02). Six eight-week-old NCG mice were injected subcutaneously into the shoulders and flanks ...
-
bioRxiv - Molecular Biology 2024Quote: ... The COMET chip with treated cells was then overlaid with 6 mL of 1% low melting agarose (catalog no. 4250-500-02, Trevigen), followed by cell lysis with 50 mL lysis solution (catalog no ...
-
bioRxiv - Microbiology 2022Quote: ... single cells were suspended in 65% reduced growth factor BME2 (Basement Membrane Extract, Type 2, Trevigen, catalogue number 3533-001-02). From this mixture ...